Isofluran Baxter

Isoflurane, the active ingredient in Isofluran Baxter, is an inhalational anesthetic presented as a solution for inhalation use. It produces rapid loss of consciousness and provides both induction and maintenance of general anesthesia for patients undergoing surgical procedures.

GNH USA supplies Isofluran Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring regulatory‑approved quality and reliable global distribution. Our network includes procurement teams and logistics partners that handle customs clearance, temperature‑controlled shipping where required, and post‑delivery support.

Isoflurane is an inhalational anesthetic that depresses central nervous system activity to facilitate surgical anesthesia. - Induction of general anesthesia: rapid loss of consciousness allowing surgical procedures to begin. - Maintenance of general anesthesia: sustained unconsciousness and analgesia throughout the operation. - Procedural sedation: provides deep sedation for short diagnostic or therapeutic interventions when a full anesthetic is not required. - Adjunct to multimodal anesthesia: reduces the required dose of other agents, improving hemodynamic stability.

Isoflurane may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Airway irritation: coughing or laryngospasm during induction. - Hypotension: reduced blood pressure due to vasodilation. - Nausea and vomiting: postoperative emesis.

Serious or Rare Side Effects: - Malignant hyperthermia: life‑threatening hypermetabolic reaction. - Cardiac arrhythmias: irregular heart rhythms requiring intervention. - Hepatotoxicity: liver enzyme elevation or injury.

When using Isoflurane, clinicians should observe specific precautions to minimize risks and ensure patient safety. - Patient monitoring: continuous ECG, blood pressure, and oxygen saturation during administration. - Hypersensitivity: avoid in individuals with known allergy to volatile anesthetics. - Cardiovascular disease: use with caution in patients with ischemic heart disease or arrhythmias. - Ventilation management: adjust fresh gas flow to prevent hypoxia and hypercapnia. - Pregnancy considerations: limit use to situations where benefits outweigh potential fetal risks. - Store at room temperature: keep container sealed, protect from light and moisture.

Isoflurane can interact with other agents, affecting its anesthetic depth and patient safety.

Major Interactions (Avoid): - Other halogenated inhalational agents: additive central nervous system depression. - Potent CYP2E1 inhibitors (e.g., disulfiram): may increase Isoflurane concentrations. - Succinylcholine: heightened risk of malignant hyperthermia.

Moderate Interactions (Monitor Closely): - Opioids: enhanced respiratory depression requiring dose adjustment. - Benzodiazepines: increased sedative effect and prolonged recovery. - Nitrous oxide: synergistic anesthetic effect that may deepen anesthesia.